CPT 85018: Hemoglobin Measurement in Whole Blood
Commercial payers pay $17 on average nationally for this procedure.
CPT code 85018 describes a laboratory procedure in which a lab analyst measures hemoglobin concentration in a whole blood sample; this is a clinical laboratory service typically performed in a hospital or outpatient laboratory setting to assess red blood cell oxygen-carrying capacity and aid evaluation of anemia or related symptoms.
For related coverage guidance, see recent payer policy updates: Hematology - Adzynma, Tumor Treating Fields for Pancreatic Cancer, Axicabtagene ciloleucel (Yescarta®) coverage.
Customize your policy alerts
Sign up for cpt 85018 policy alerts
Get alerted when payer policies referencing 85018 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
For CPT 85018, BUCA’s average commercial rate sits at $17.10, representing a mid-market reference point across national commercial payers. Blue Cross Blue Shield displays a relatively narrow interquartile spread (P75 $17.00 minus P25 $9.90 = $7.10), and UnitedHealth Group also shows tight dispersion (P75 $2.80 minus P25 $1.40 = $1.40), indicating more consistent contracted rates. Cigna’s spread is modest (P75 $4.20 minus P25 $1.90 = $2.30), while Aetna exhibits the widest dispersion by far (P75 $7.10 minus P25 $2.00 = $5.10) when considering its very large maximum outlier.
Blue Cross Blue Shield and UnitedHealth Group therefore represent the tightest interquartile consistency among listed payers, with ranges of $7.10 and $1.40 respectively, while Aetna shows the broadest middle-range variability at $5.10. Cigna and BUCA fall between those extremes, with Cigna’s IQR at $2.30 and BUCA’s interquartile range at $5.30 (P75 $11.70 minus P25 $6.40 = $5.30), reflecting moderate dispersion around BUCA’s $17.10 average.